| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00110721 Details | 2012-03-06 Interventional | 2 | 20 | Fluorouracil Colorectal Neop… Colorectal Canc… | Study protocol amended to a new treatment regimen: study DAVFU-006. - | |||
| NCT01053884 2009-014527-23 Details | 2012-03-02 Interventional | 2 | 10 | Anidulafungin Hematologic Neo… Neoplasms Hematologic Mal… | reduced recruitment rate due to non infectious, but competitive trials at our institution - | |||
| NCT00673270 Details | 2012-03-02 Interventional | 1/2 | 13 | Fludrocortisone Hydrocortisone Hydrocortisone … Hydrocortisone … Hydrocortisone … Renin Angiotens… | - - | |||
| NCT00336882 2005-006213-40 Details | 2012-03-02 Interventional | 3 | 30 | Midazolam Propofol Brain Injuries Brain Injuries,… Craniocerebral … Traumatic Brain… | - - | |||
| NCT00317850 Details | 2012-03-02 Interventional | 2/3 | - | Gabapentin Tinnitus | - - | |||
| NCT01257412 Details | 2012-03-01 Interventional | 3 | - | Dapagliflozin Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes | FSI delayed until 15 January 2013 - | |||
| NCT00762957 Details | 2012-02-28 Interventional | 3 | 15 | Metformin Diabetes Mellit… Diabetes Mellit… | Hepatic Safety Signal Identified. - | |||
| NCT00521820 Details | 2012-02-28 Interventional | 3 | [1 Refs] | 518 | Glyburide Pioglitazone Diabetes Mellit… Heart Failure | Higher incidence of hospitalization for congestive heart failure in pioglitazone-treated
subjects compared to glyburide treated subjects. - | ||
| NCT00768989 Details | 2012-02-24 Interventional | 2 | 167 | Atazanavir Sulf… Emtricitabine Raltegravir Pot… Ritonavir Tenofovir HIV | Efficacy endpoint met, but overall experimental dosing regimen not considered optimal to
support further clinical development in this population. - | |||
| NCT01244620 Details | 2012-02-22 Interventional | 1 | 16 | Sildenafil Citr… Sitaxsentan Tadalafil Pulmonary Arter… | Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
specifically new emerging evidence of hepatic injury. Study endpoints were not analyzed due to early termination. | |||
| NCT00003714 Details | 2012-02-22 Interventional | 2 | 0 | NSC 366140 Liver Neoplasms Liver Cancer Metastatic Canc… | Withdrawn - | |||
| NCT00003599 Details | 2012-02-22 Interventional | 3 | 0 | Isotretinoin Tocopherols Vitamin E alpha-Tocophero… Lung Neoplasms Lung Cancer | Withdrawn study. - | |||
| NCT00003564 Details | 2012-02-22 Interventional | 3 | 0 | Isotretinoin Procarbazine Central Nervous… Glioma Nervous System … Brain and Centr… | Study withdrawn. - | |||
| NCT00900146 Details | 2012-02-20 Interventional | 2/3 | 556 | Metformin Diabetes Mellit… | Numerically modest lowering of HbA1c with canakinumab in combination with metformin was
inadequate to continue patients with T2DM into Period IV of this study. - | |||
| NCT00005969 Details | 2012-02-20 Interventional | 2 | 0 | Tretinoin Hodgkin Disease Lymphoma | Study withdrawn. - | |||
| NCT01035593 Details | 2012-02-17 Interventional | 2 | 0 | Complement C1 I… Angioedemas, He… Graft Rejection Kidney Transpla… | Recent improvements in clinical practice have reduced the apparent incidence of AMR in renal
transplantation. - | |||
| NCT00724256 Details | 2012-02-17 Interventional | 3 | 36 | Ceftibuten Pyelonephritis | other upcoming studies; patients refusal of invasive follow up (DMSA) - | |||
| NCT00267280 Details | 2012-02-17 Interventional | 3 | - | Atorvastatin Simvastatin Torcetrapib Dyslipidemias Hypercholestero… Hyperlipidemias Dyslipidemia Hyperlipidemia | - - | |||
| NCT00145431 Details | 2012-02-17 Interventional | 3 | 41 | Atorvastatin Fenofibrate Torcetrapib Hyperlipidemias Hyperlipoprotei… Hyperlipoprotei… | - - | |||
| NCT00134238 Details | 2012-02-17 Interventional | 3 | 755 | Atorvastatin Torcetrapib Hyperlipidemia,… Hyperlipidemias Hyperlipoprotei… Hyperlipoprotei… Lipidoses Mixed Hyperlipi… | - - |